Agilent Technologies and Monash University Sunway campus have announced a collaboration to promote talent and skills development for genomics research in Malaysia.
Agilent Technologies and Monash University Sunway campus have announced a collaboration to promote talent and skills development for genomics research in Malaysia.
The partnership with a university in Malaysia is the first of its kind for Agilent and will help Malaysia to assert itself as a leading centre for life sciences research and development in Southeast Asia.
A centre of excellence, known as the Monash-Agilent Authorized Microarray Service Centre (AMSC), will be established at Monash University Sunway campus and will see knowledge-sharing between both organizations. The centre will be equipped with the latest microarray instruments and will provide competency training for the centre’s lab professionals.
Professor Dato’ Dr Anuar Zaini Md Zain, head of the school, said, “The establishment of the AMSC will be a timely boost in the collaboration between Agilent and Monash University Sunway campus, providing the opportunity to access advanced technologies to strengthen our current genomics research in diabetes, cancer, neurobiology and infectious diseases. The centre, together with existing technologies at the school, such as liquid chromatography/mass spectrometry and proteomics, will encourage integrative and multidisciplinary research.”
Rod Minett, general manager, Agilent Life Sciences Group, South Asia Pacific and Korea, said, “We are excited about this collaboration with Monash University Sunway campus. The knowledge gleaned from the collaboration will not only contribute towards further understanding and preventing diseases, but also cement Malaysia as a centre for life sciences research and development.”
For more information please visit ref="http://www.agilent.com">www.agilent.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.